Apply Now: Deadline is January 15 for FUS + Cancer Immunotherapy Funding
Funding Available for FUS + Cancer Immunotherapy Projects
In June, the Foundation partnered with the Cancer Research Institute to advance the development of new focused ultrasound (FUS) and cancer immunotherapy treatments. Both organizations recognize the intersection of the latest developments in FUS therapy and cancer immunotherapy offers a highly promising opportunity for combination approaches to treat a variety of cancers.
As a key component of this partnership, we established a grant program to jointly fund research projects that will help investigate new focused ultrasound and cancer immunotherapy combination treatments.
This first request for proposals seeks preclinical projects to answer the following research question:
How do different “modes” of focused ultrasound (i.e. ablative vs. non-ablative, thermal vs. mechanical) compare in terms of the immune response generated, and how does this immune response correlate with biological, acoustic and imaging metrics?
We encourage you to apply and share this opportunity with your colleagues.
Projects are eligible for up to $200,000 over two years, and letters of intent are due January 15.